Press release
Investigation announced for Long-Term Investors in shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP)
An investigation on behalf of current long term investors in NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) shares.
Investors who are current long term investors in NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: NRXP stocks follows a lawsuit filed against NRx Pharmaceuticals, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: NRXP stocks, concerns whether certain NRx Pharmaceuticals, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of Delaware the plaintiff alleges that, the Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the ZYESAMI EUA Application contained insufficient data regarding the potential benefits and risks of ZYESAMI; (ii) accordingly, the FDA was unlikely to approve the ZYESAMI EUA Application in its present form; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) here
News-ID: 2621219 • Views: …
More Releases from Shareholders Foundation
Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareh …
An investigation was announced concerning whether the takeover of Thoughtworks Holding, Inc. is unfair to NASDAQ: TWKS stockholders.
Investors who purchased shares of Thoughtworks Holding, Inc. (NASDAQ: TWKS) and currently hold any of those NASDAQ: TWKS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Thoughtworks Holding, Inc. breached their…
Investigation announced for Investors who lost money with shares of Domino's Piz …
An investigation was announced for investors of Domino's Pizza, Inc. (NYSE: DPZ) shares over potential securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Domino's Pizza, Inc. (NYSE: DPZ)…
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc.
Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged…
Investigation announced for Investors who lost money with shares of Dayforce Inc …
An investigation was announced for investors of Dayforce Inc (NYSE: DAY) shares over potential securities laws violations by Dayforce Inc.
Investors who purchased shares of Dayforce Inc (NYSE: DAY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Dayforce Inc regarding its business, its prospects and its operations were materially…
More Releases for NRx
Bipolar Depression Pipeline Drugs and Companies Insight Report: Analysis of Clin …
Bipolar Depression pipeline constitutes 6+ key companies continuously working towards developing 6+ Bipolar Depression treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
Bipolar Depression Overview
Bipolar disorder is a disabling chronic disease in which depression usually presents a higher risk of long-term functional impairment than mania. Persistent depression does not have a known cause. As with bipolar disorder, depression has hereditary…
The Bipolar Depression Market is growing at a Significant CAGR Driven by the Pot …
DelveInsight's Bipolar Depression market report provides thorough comprehension of Bipolar Depression, historical and forecasted epidemiology, and Bipolar Depression market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan).
As per DelveInsight analysis, the Bipolar Depression market will experience a significant impact in the coming years owing to the increase in awareness and technology, advancement towards precision medicine, expected launch of emerging drugs, entry…
Deadline on March 21st coming up in Lawsuit for Investors in NRx Pharmaceuticals …
A deadline is coming up on March 21, 2022 in the lawsuit filed for certain investors of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) over alleged securities laws violations by NRx Pharmaceuticals, Inc. (NASDAQ: NRXP).
Investors who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and there are strict and short deadlines running. Deadline: March 21, 2022. NASDAQ: NRXP stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors in shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP …
An investor, who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), filed a lawsuit over alleged violations of Federal Securities Laws by NRx Pharmaceuticals, Inc.
Investors who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and for certain investors are short and strict deadlines running. Deadline: March 21, 2022. NASDAQ: NRXP investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Wilmington, DE based NRX…
The COVID-19 Therapeutics Market Research Report 2021| Key Player: Celltrion Hea …
InsightAce Analytic Pvt. Ltd. announces the market assessment report on “Global COVID-19 Therapeutics Market– By Trends, Industry Competition Analysis, Clinical Trial/Pipeline Analysis, Revenue and Forecast Till 2030.”
Request for Sample Pages: https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184
According to the latest market intelligence report by InsightAce Analytic, the global COVID-19 therapeutics market size is valued at US$ 5.26 Billion in 2020, and it is expected to reach US$ 25.6 Billion in 2030, recording a promising CAGR of…
Electronic Cigarette Oil Market is Likely to Witness huge Growth - Key Players a …
Up Market Research added a new Electronic Cigarette Oil Market research report for the period of 2019 – 2026. Report focuses on the major drivers and restraints providing analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.
Get Exclusive FREE Sample Copy Of this Report @
https://www.upmarketresearch.com/home/requested_sample/80852
The report contains pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue…
